OMEGA-3 POLYUNSATURATED FATTY ACIDS AND COGNITIVE DEVELOPMENT OF CHILDREN
Abstract
Omega-3 polyunsaturated fatty acids (PUFA) are important nutrient for proper support of normal living. Omega-3 PUFA play significant role in neurogenesis, neurotransmission, neuroprotection, they are necessary for development of human’s brain. Present study discusses results of fundamental and clinical studies on role of omega-3 PUFA in ontogenesis. Authors performed systematic analysis of physiological effects of omega-3 PUFA on molecular level. Deficiency of omega-3 PUFA results in decrease of intellect and increase of hyperactivity in children. The necessity of proper administration of omega-3 PUFA in early pre-school period and in younger schoolchildren is confirmed by results of clinical studies.
About the Authors
O. A. Gromova
Russian Collaborating Center, Institute of Microelements, UNESCO, Moscow
Ivanovo State Medical Academy
Russian Federation
Russian Federation
I. Yu. Torshin
Russian Collaborating Center, Institute of Microelements, UNESCO, Moscow
Russian Federation
Russian Federation
Ye. Yu. Yegorova
Ivanovo State University
Russian Federation
Russian Federation
References
1. Heemskerk J. W., Vossen R. C., van Dam-Mieras M. C. Polyunsaturated fatty acids and function of platelets and endothelial cells // Curr. Opin. Lipidol. — 1996; 7: 24–29.
2. Громова О. А., Торшин И. Ю., Сухих Г. Т. и др. Роли различных форм омега-3 ПНЖК в акушерстве и неонатологии. — М., 2009. — 64 с.
3. Innis S. M. Dietary (n-3) fatty acids and brain development // J. Nutr. — 2007; 137 (4): 855–859.
4. McNamara R. K., Carlson S. E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology // Prostaglandins Leukot. Essent. Fatty. Acids. — 2006; 75 (4–5): 329–349.
5. Cohen J. T., Bellinger D. C., Connor W. E., Shaywitz B. A. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development // Am. J. Prev. Med. — 2005; 29 (4): 366–374.
6. Ryan A. S., Astwood J. D., Gautier S. et al. Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies // Prostaglandins Leukot. Essent. Fatty. Acids. — 2010; 82 (4–6): 305–314.
7. Kirby A., Woodward A., Jackson S. et al. A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8–10 years from a mainstream school population // Res. Dev. Disabil. — 2010; 31 (3): 718–730.
8. Eilander A., Hundscheid D. C., Osendarp S. J. et al. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies // Prostaglandins Leukot. Essent. Fatty. Acids. — 2007; 76 (4): 189–203.
9. Бурцев Е. М. Нарушения мозгового кровообращения в молодом возрасте. — М.: Медицина, 1978. — 457 с.
10. Волосовец А. П., Кривопустов С. П. Инсульт головного мозга и инфаркт миокарда у детей: современный взгляд на проблему // Здоровье ребенка. — 2006; 2 (2): 12–20.
11. Kang J. X., Leaf A. Antiarrhythmic effects of polyunsaturated fatty acids // Lipids. — 1996; 31 (Suppl.): 41–44.
12. Serhan C. N. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins // Curr. Opin. Clin. Nutr. Metab. Care. — 2005; 8 (2): 115–121.
13. Bazan N. G. The onset of brain injury and neurodegeneration triggers the synthesis of docosanoid neuroprotective signaling // Cell Mol. Neurobiol. — 2006; 26 (4–6): 901–913.
14. Bazan N. G. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection // Curr. Opin. Clin. Nutr. Metab. Care. — 2007; 10 (2): 136–141.
15. Ortmann O., Catt K. J., Schulz K. D., Emons G. Modulatory action of progesterone and progesterone antagonists on hypothalamicpituitary function // Hum Reprod. — 1994; 9 (1): 53–62.
16. Catalan J., Moriguchi T., Slotnick B. et al. Cognitive deficits in docosahexaenoic acid-deficient rats // Behav. Neurosci. — 2002; 116 (6): 1022–1031.
17. Jiang L. H., Shi Y., Wang L. S., Yang Z. R. The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice // J. Nutr. Biochem. — 2009; 20 (9): 735–741.
18. Muggli R. LCFUPA and brain health. — DSM Nutritional Рroducts, 2007. — Р. 4.
19. Van Eijsden M., Hornstra G., van der Wal M. F. et al. Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study // Am. J. Clin. Nutr. — 2008; 87 (4): 887–895.
20. Helland I. B., Saugstad O. D., Smith L. et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women // Pediatrics. — 2001; 108 (5): 82.
21. Smithers L. G., Gibson R. A., McPhee A., Makrides M. Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial // Am. J. Clin. Nutr. — 2008; 88 (4): 1049–1056.
22. Judge M. P., Harel O., Lammi-Keefe C. J. A docosahexaenoic acidfunctional food during pregnancy benefits infant visual acuity at four but not six months of age // Lipids. — 2007; 42 (2): 117–23.
23. Jorgensen M. H., Hernell O., Hughes E., Michaelsen K. F. Is there a relation between docosahexaenoic acid concentration in mothers' milk and visual development in term infants? // J. Pediatr. Gastroenterol. Nutr. — 2001; 32 (3): 293–296.
24. Henriksen C., Haugholt K., Lindgren M. et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid // Pediatrics. — 2008; 121 (6): 1137–1145.
25. Ryan A. S., Nelson E. B. Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study // Clin. Pediatr. (Phila). — 2008; 47 (4): 355–362.
26. Cohen J. T., Bellinger D. C., Connor W. E., Shaywitz B. A. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development // Am. J. Prev. Med. — 2005; 29 (4): 366–374.
27. Bakker E. C. Long-chain polyunsaturated fatty acids at birth and motor function at 7 years of age, in Long-chain polyunsaturated fatty acids and child development. — Maastricht: Universitaire Pers, 2002. — Р. 47–102.
28. Ikemoto A., Ohishi M., Sato Y. et al. Reversibility of n-3 fatty acid deficiency-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor // J. Lipid. Res. — 2001; 42 (10): 1655–1663.
29. Rader R., McCauley L., Callen E. C. Current strategies in the diagnosis and treatment of childhood attention-deficit/hyperactivity disorder // Am. Fam. Physician. — 2009; 79 (8): 657–665.
30. Van Cleave J., Leslie L. K. Approaching ADHD as a chronic condition: implications for long-term adherence // J. Psychosoc. Nurs. Ment. Health Serv. — 2008; 46 (8): 28–37.
31. Журба Л. Т., Мастюкова Е. М. Минимальная мозговая дисфункция у детей. — М.: ВИНИМИ, 1980. — 92 c.
32. Заваденко Н. Н., Суворинова Н. Ю., Румянцева М. В. Гипер активность с дефицитом внимания: факторы риска, возрастная динамика, особенности диагностики // Дефектология. — 2003; 6: 6–11.
33. Торшин И. Ю., Громова О. А., Скоромец А. Н., Егорова Е. Ю. Систематический анализ биохимических нарушений при синдроме дефицита внимания с гиперактивностью: нутрициологическая концепция // Педиатрия. — 2010; 12.
34. Linnet K. M., Dalsgaard S., Obel C. et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence // Am. J. Psychiatry. — 2003; 160 (6): 1028–1040.
35. Braun J. M., Kahn R. S., Froehlich T. et al. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U. S. children // Environ. Health Perspect. — 2006; 114 (12): 1904–1909.
36. McCann D., Barrett A., Cooper A. et al. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial // Lancet. — 2007; 370 (9598): 1560–1567.
37. Kuehn B. M. Increased risk of ADHD associated with early exposure to pesticides, PCBs // JAMA. — 2010; 304 (1): 27–28.
38. Germano M., Meleleo D., Montorfano G. et al. Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD) // Nutr. Neurosci. — 2007; 10 (1–2): 1–9.
39. Liu P. J., Ma F. Polyunsaturated fatty acids and attention-deficit hyperactivity disorder // Zhongguo Dang Dai Er Ke Za Zhi. — 2009; 11 (9): 783–785.
40. Schuchardt J. P., Huss M., Stauss-Grabo M., Hahn A. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children // Eur. J. Pediatr. — 2010; 169 (2): 149–164.
41. Lavialle M., Denis I., Guesnet P., Vancassel S. Involvement of omega-3 fatty acids in emotional responses and hyperactive symptoms // J. Nutr. Biochem. — 2010; 21 (10): 899–905.
42. Lavialle M., Champeil-Potokar G., Alessandri J. M. et al. An (n-3) polyunsaturated fatty acid-deficient diet disturbs daily locomotor activity, melatonin rhythm, and striatal dopamine in Syrian hamsters // J. Nutr. — 2008; 138 (9): 1719–1724.
43. McNamara R. K., Able J., Jandacek R. et al. Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, doseranging, functional magnetic resonance imaging study // Am. J. Clin. Nutr. — 2010; 91 (4): 1060–1067.
44. Colter A. L., Cutler C., Meckling K. A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study // Nutr. J. — 2008; 7 (1): 8–10.
45. Young G. S., Maharaj N. J., Conquer J. A. Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder // Lipids. — 2004; 39 (2): 117–123.
46. Spahis S., Vanasse M., Belanger S. A. et al. Lipid profile, fatty acid composition and proand anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder // Prostaglandins Leukot. Essent. Fatty. Acids. — 2008; 79 (1–2): 47–53.
47. Antalis C. J., Stevens L.J., Campbell M. et al. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder // Prostaglandins Leukot. Essent. Fatty. Acids. — 2006; 75 (4–5): 299–308.
48. Кузенкова Л. М., Балканская С. В., Увакина Е. В. Место микронутриентов и полиненасыщенных жирных кислот в профилактике когнитивных нарушений у детей с синдромом дефицита внимания и гиперактивности. — М., 2010.
Review
For citations:
Gromova O.A., Torshin I.Yu., Yegorova Ye.Yu. OMEGA-3 POLYUNSATURATED FATTY ACIDS AND COGNITIVE DEVELOPMENT OF CHILDREN. Current Pediatrics. 2011;10(1):66-72. (In Russ.)
Views:
1596
Email this article 
